摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

α-amanitin | 23109-05-9

中文名称
——
中文别名
——
英文名称
α-amanitin
英文别名
alpha-amanitin;Alpha Amanitin;2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-13-[(2R,3R)-3,4-dihydroxybutan-2-yl]-8,22-dihydroxy-2,5,11,14,27,30,33,36,39-nonaoxo-27λ4-thia-3,6,12,15,25,29,32,35,38-nonazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide
α-amanitin化学式
CAS
23109-05-9
化学式
C39H54N10O14S
mdl
——
分子量
918.982
InChiKey
CIORWBWIBBPXCG-JAXJKTSHSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    254-255 °C(lit.)
  • 比旋光度:
    D20 +191°
  • 沸点:
    1622.2±65.0 °C(Predicted)
  • 密度:
    1.1626 (rough estimate)
  • 溶解度:
    H2O:1.0 mg/mL
  • 颜色/状态:
    NEEDLES FROM METHANOL
  • 旋光度:
    SPECIFIC OPTICAL ROTATION: +191 DEG @ 20 °C/D; MAX ABSORPTION: 302 NM

计算性质

  • 辛醇/水分配系数(LogP):
    -4.4
  • 重原子数:
    64
  • 可旋转键数:
    7
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.56
  • 拓扑面积:
    400
  • 氢给体数:
    13
  • 氢受体数:
    15

ADMET

毒理性
  • 在妊娠和哺乳期间的影响
◉ 母乳喂养期间的使用总结:鹅膏毒肽是一类溶性、热稳定的肽类,存在于鹅膏属(最常见的是鹅膏蕈)、鹅膏环柄菇属和某些鳞伞属物种中。从鹅膏蕈中提取的主要毒素是alpha-amanitin,一种环状八肽。它是一种强烈的RNA聚合酶抑制剂,可以阻止肝脏和肾脏细胞中mRNA的产生和蛋白质合成。在一个案例中,一位母亲食用鹅膏蕈后11.5小时哺乳一次,婴儿出现肝酶升高。然而,最近两个详细记录的案例发现哺乳婴儿没有不良反应,乳汁中没有鹅膏毒肽。尽管如此,疑似食用鹅膏蕈中毒的母亲在恢复之前或对母乳进行毒理学筛查排除之前,可能不应该哺乳。 ◉ 对哺乳婴儿的影响:在德国,一位20岁的哺乳母亲吃了一顿仅由蘑菇组成的餐食,报告将其识别为绿色块菌(鹅膏蕈)。蘑菇摄入后的第二天早上大约11.5小时,她给她的10周大,体重5公斤的婴儿喂奶。这顿饭包括80到100毫升的母乳和同样数量的即食婴儿配方奶粉(MiLAsan-Neu)。此时,母亲已经出现中毒症状(呕吐和腹泻)。由于病情恶化,她无法继续哺乳孩子,所以孩子之后只接受了配方奶粉。母亲因鹅膏蕈中毒被送往医院,其ASAT和ALAT值分别为10,000和40,000(正常值约为500-550)。婴儿被送往儿童医院接受住院观察。婴儿的亲属没有注意到孩子有任何不寻常的地方,临床入院检查也没有发现明显的肝脏、大脑或血液疾病的迹象。母亲食用蘑菇后6天,婴儿的实验室检查值(电解质、血清电泳、胆红素、gamma-GT、碱性磷酸酶、肌酐、血糖、尿液状态、PTTPT[快速测试])都正常,除了ASAT和ALAT大约是正常值的两倍。这些值在摄入后大约40天逐渐下降并恢复正常。 一位32岁的母亲与家人共享了一顿采摘的蘑菇(Amanita bisporigera)大餐,摄入后15小时出现症状。她在摄入后29小时到急诊科就诊,被发现肝酶显著升高。她4个月大的女儿在摄入后4小时哺乳。哺乳后48小时评估的无症状婴儿从急诊科出院,没有肝毒性的证据。 一位33岁的妇女在法国的森林里采摘了大约200个蘑菇。她烹饪并食用了一些,摄入后11小时出现恶心、呕吐和腹泻。她因治疗被送往医院,肝酶升高。她在蘑菇摄入后的36小时内,每天三次给5个月大的女儿哺乳。她的女儿被住院,但没有出现任何症状或生物学干扰。 ◉ 对泌乳和母乳的影响:截至修订日期,没有找到相关的已发布信息。
◉ Summary of Use during Lactation:Amatoxins are water soluble, heat stable polypeptides found in Amanita (most often Amanita phalloides ), Galerina and some Lepiota species. The main toxin from the species A. phalloides is alpha-amanitin, a cyclic octapeptide. It is a potent inhibitor of RNA polymerases that blocks the production of mRNA and protein synthesis in liver and kidney cells. In one case, an infant developed elevated liver enzymes after nursing once 11.5 hours after maternal ingestion of Amanita phalloides. However, two recent, well-documented cases found no adverse effects in breastfed infants and no amatoxin in the milk. Nevertheless, mothers suspected of having Amanita mushroom poisoning probably should not breastfeed until they have recovered or toxicologic screening of the breastmilk has ruled out. ◉ Effects in Breastfed Infants:In Germany, a 20-year-old nursing mother ate a meal of solely mushrooms identified in the report as green tuberous mushroom (Amanita phalloides). The next morning around 11.5 hours after mushroom ingestion, she nursed her 10-week-old infant who weighed 5 kg. The meal consisted of 80 to 100 mL of breastmilk and the same amount of ready-to-use infant formula (Milasan-Neu). At this time the mother already had symptoms of intoxication (vomiting and diarrhea). Because of the deterioration in her condition she was unable to continue breastfeeding the child, so the child received only formula thereafter. After the mother was admitted to the hospital for Amanita phalloides poisoning and had ASAT and ALAT values of 10,000 and 40,000, respectively (normal values about 500-550). The infant was placed under inpatient observation at children’s hospital. The infant’s relatives noticed nothing unusual about the child and the clinical admission examination revealed no visible evidence of a hepatic, cerebral or hematological disease. Six days after maternal mushroom ingestion, the infant’s laboratory values (electrolytes, serum electrophoresis, bilirubin, gamma-GT, alkaline phosphatase, creatinine, blood sugar, urine status, PTT, and PT [Quick test]) were normal except for ASAT and ALAT, which were about double the normal value. These values slowly decreased and became normal at about day 40 after ingestion. A 32-year-old mother shared a meal of foraged mushrooms (Amanita bisporigera), and developed symptoms 15 hours post-ingestion. She presented to the emergency department 29 hours post-ingestion and was found to have markedly elevated liver enzymes. Her 4 month-old-daughter had breastfed 4 hours post-ingestion. The asymptomatic infant was evaluated 48 hours after breastfeeding and discharged from the emergency department with no evidence of hepatotoxicity. A 33-year-old woman picked about 200 mushrooms in a forest in France. She cooked and ate some of them, and developed nausea, vomiting and diarrhea 11 hours post-ingestion. She was admitted to the hospital for treatment and had elevated liver enzymes. She had breastfed her 5-month-old daughter 3 times a day over the 36 hours after mushroom ingestion. Her daughter was hospitalized, but did not present any symptoms, nor any biological disturbance. ◉ Effects on Lactation and Breastmilk:Relevant published information was not found as of the revision date.
来源:Drugs and Lactation Database (LactMed)
毒理性
  • 副作用
职业性肝毒素 - 第二性肝毒素:在职业环境中的毒性效应潜力是基于人类摄入或动物实验的中毒病例。
Occupational hepatotoxin - Secondary hepatotoxins: the potential for toxic effect in the occupational setting is based on cases of poisoning by human ingestion or animal experimentation.
来源:Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
毒理性
  • 相互作用
...药物制剂.../已经/据报道可以保护小鼠免受致死剂量的蟒毒素和鹅膏毒素/包括鹅膏菌素/。这个清单包括高剂量的青霉素氯霉素非那西丁以及许多其他药物...这些解毒剂中没有一种经过充分临床试验,因此目前不能推荐使用。/鹅膏菌素/
...PHARMACOLOGICAL AGENTS.../HAVE/ BEEN REPORTED TO PROTECT MICE AGAINST LETHAL DOSES OF PHALLOTOXINS & AMATOXINS /INCLUDING THE AMANITINS/. THE LIST INCLUDES HIGH DOSES OF PENICILLIN, CHLORAMPHENICOL, PHENYLBUTAZONE, & MANY OTHERS... NONE OF THESE ANTIDOTES HAS RECEIVED AN ADEQUATE CLINICAL TRIAL & SO NONE CAN BE RECOMMENDED TODAY. /AMANITINS/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 相互作用
RNA SYNTHESIS IN HELA NUCLEI WAS STIMULATED BY METHYLMERCURY. THIS STIMULATION IS SPECIFIC FOR ALPHA-AMANITIN-SENSITIVE RNA SYNTHESIS (CATALYZED BY RNA POLYMERASE); IN CONTRAST, ALPHA-AMANITIN-RESISTANT SYNTHESIS (CATALYZED BY RNA POLYMERASES I & III) WAS INHIBITED. 海拉细胞核中的RNA合成被甲基汞刺激。这种刺激对α-鹅膏蕈素敏感的RNA合成(由RNA聚合酶催化)具有特异性;相比之下,对α-鹅膏蕈素抵抗的合成(由RNA聚合酶I和III催化)被抑制。
RNA SYNTHESIS IN HELA NUCLEI WAS STIMULATED BY METHYLMERCURY. THIS STIMULATION IS SPECIFIC FOR ALPHA-AMANITIN-SENSITIVE RNA SYNTHESIS (CATALYZED BY RNA POLYMERASE); IN CONTRAST, ALPHA-AMANITIN-RESISTANT SYNTHESIS (CATALYZED BY RNA POLYMERASES I & III) WAS INHIBITED.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 解毒与急救
实验用途:研究了未涂层的活性炭柱(脱氧基2,索林生物医学)对α-鹅膏蕈碱的吸附能力,方法是将已知数量的α-鹅膏蕈碱添加到新鲜的人血中,然后通过临床血液透析回路循环回输30分钟。在酸洗液中存在适当数量的α-鹅膏蕈碱,表明血液浓度在50至200纳克/毫升范围内有最佳的吸附效果。讨论了活性炭血液透析在毒鹅膏中毒的临床实用性。
EXPTL USE: THE SORBENT CAPACITY OF UNCOATED CHARCOAL COLUMN (DETOXYL 2, SORIN BIOMEDICA) ON ALPHA-AMANITIN WAS STUDIED BY ADDING KNOWN AMOUNTS TO FRESH HUMAN BLOOD, WHICH WAS RECIRCULATED THROUGH A CLINICAL HEMOPERFUSION CIRCUIT OVER A PERIOD OF 30 MINUTES. SUITABLE AMOUNTS OF ALPHA-AMANITIN WERE PRESENT IN THE ACID ELUATES, SHOWING AN ADSORPTION OPTIMUM FOR BLOOD CONCN RANGING FROM 50 TO 200 NG/ML. THE CLINICAL USEFULNESS OF CHARCOAL HEMOPERFUSION IN AMANITA PHALLOIDES POISONING IS DISCUSSED.
来源:Hazardous Substances Data Bank (HSDB)

安全信息

  • 危险等级:
    6.1(a)
  • 危险品标志:
    T+
  • 安全说明:
    S28,S36/37,S36/37/39,S45
  • 危险类别码:
    R26/27/28
  • WGK Germany:
    3
  • 危险品运输编号:
    UN 3462 6
  • 包装等级:
    I
  • 危险类别:
    6.1(a)

SDS

SDS:ee5da1c88df27f4c6d9392eccf4e4fee
查看

制备方法与用途

简介

蘑菇毒鹅膏,又称“致命鹅膏毒蕈”,学名为 Amanita phalloides。这种真菌拥有悠久的历史,曾被用于谋杀和自杀,在古罗马时代便已有记录。它能产生世界上毒性最强的毒素之一——α-鹅膏蕈碱。尽管合成这种毒素起初看似荒谬,但科研人员已发现它可能在治疗癌症方面发挥重要作用,并在美国化学学会的期刊上报道了合成过程。

理化活性

剧毒鹅膏中的鹅膏毒肽可溶于且性质稳定,在高温和酸碱条件下不易失活。烹饪无法破坏这些毒素。一旦进入人体,鹅膏毒肽会被消化道吸收,进而经血液循环到达肝细胞。它能与RNA聚合酶结合,抑制信使RNA的合成,从而干扰细胞代谢。鹅膏毒肽从聚合酶中解离后会进入胆汁,随胆汁流入小肠再次被吸收,经过血液循环回到肝脏,形成肠肝循环路径,对肝脏造成反复损害。

类别
  • 有毒物品
  • 毒性分级:剧毒
  • 急性毒性:腹腔注射 - 小鼠 LD50: 0.1毫克/公斤
  • 可燃性危险特性:可燃;燃烧会产生有毒的氮氧化物和氧化物烟雾
储运与灭火
  • 库房通风、低温干燥储存
  • 灭火剂:干粉、泡沫、砂土、二氧化碳、雾状

反应信息

  • 作为反应物:
    描述:
    α-amanitin三乙胺N,N-二异丙基乙胺Methanaminium,N-[(dimethylamino)(3H-1,2,3-triazolo[4,5-b]pyridin-3-yloxy)methylene]-N-methyl-, hexafluorophosphate(1-)三氟乙酸 作用下, 以 甲醇N,N-二甲基甲酰胺 为溶剂, 反应 75.02h, 生成 6’O-methyl-7’C-((6-(aminoxy)hexaneamido)-ethylthiomethyl)-α-amanitin
    参考文献:
    名称:
    [EN] AMATOXIN DERIVATIVES AND CONJUGATES THEREOF AS INHIBITORS OF RNA POLYMERASE
    [FR] DÉRIVÉS D'AMATOXINE ET LEURS CONJUGUÉS COMME INHIBITEURS DE L'ARN POLYMÉRASE
    摘要:
    本发明涉及一种公式(I)的细胞毒性环肽,使用这种环肽抑制RNA聚合酶的方法,包含这种环肽的免疫结合物(即抗体药物结合物),包含这种环肽免疫结合物的药物组合物,包含这种环肽免疫结合物和治疗辅助剂的组合物以及使用这种环肽免疫结合物进行治疗的方法:公式(I)。
    公开号:
    WO2016071856A1
  • 作为产物:
    描述:
    C46H60N10O13S 在 三氟化硼乙醚间氯过氧苯甲酸乙硫醇 作用下, 以 乙醇异丙醇 为溶剂, 反应 2.5h, 生成 α-amanitin
    参考文献:
    名称:
    [EN] METHOD FOR SYNTHESIS OF THIOETHER-CONTAINING PEPTIDES
    [FR] PROCÉDÉ DE SYNTHÈSE DE PEPTIDES CONTENANT DU THIOÉTHER
    摘要:
    本发明涉及一种在固相肽合成中,在碘处理下形成色氨酸和半胱氨酸之间硫桥的方法。该发明还涉及所述方法得到的化合物及其各自的用途。
    公开号:
    WO2021250059A1
点击查看最新优质反应信息

文献信息

  • Di-substituted maleic amide linker for antibody drug conjugating and preparation method and use thereof
    申请人:Mabwell (shanghai) Bioscience Co., Ltd.
    公开号:US10987430B2
    公开(公告)日:2021-04-27
    Provided in the present invention are a di-substituted maleic amide linker conjugated to an antibody and a preparation method and use thereof. In particular, the present invention conjugates a strongly cytotoxic active substance to a biomacromolecule through a class of new linkers. The class of linkers can selectively act simultaneously with disulphide chains, so as to greatly improve the substance homogeneity of a conjugate. The conjugate prepared by the linker of the present invention has a high inhibitory activity on a cell strain expressing the corresponding antigen. Also provided is a method for preparing the above-mentioned conjugate and the use.
    本发明提供了一种二取代马来酰胺连接物与抗体结合的制备方法及其用途。具体而言,本发明通过一类新连接物将一种强烈细胞毒活性物质与生物大分子结合。这类连接物可以与二键同时选择性地作用,从而极大地提高结合物质的均一性。本发明连接物制备的结合物对表达相应抗原的细胞株具有高抑制活性。还提供了制备上述结合物的方法和用途。
  • [EN] CONJUGATES COMPRISING PEPTIDE GROUPS AND METHODS RELATED THERETO<br/>[FR] CONJUGUÉS COMPRENANT DES GROUPES PEPTIDIQUES ET PROCÉDÉS ASSOCIÉS À CEUX-CI
    申请人:LEGOCHEM BIOSCIENCES INC
    公开号:WO2017089894A1
    公开(公告)日:2017-06-01
    In some aspects, the invention relates to an antibody-drug conjugate, comprising an antibody; a linker; and at least two active agents. In preferred embodiments, the linker comprises a peptide sequence of a plurality of amino acids, and at least two of the active agents are covalently coupled to side chains of the amino acids. The antibody-drug conjugate may comprise a self-immolative group, preferably two-self-immolative groups. The linker may comprise an O-substituted oxime, e.g., wherein the oxygen atom of the oxime is substituted with a group that covalently links the oxime to the active agent; and the carbon atom of the oxime is substituted with a group that covalently links the oxime to the antibody.
    在某些方面,本发明涉及一种抗体药物偶联物,包括:抗体;连接体;以及至少两个活性剂。在优选的实施例中,连接体包括由多个氨基酸组成的肽序列,其中至少两个活性剂通过共价键与氨基酸的侧链连接。抗体药物偶联物可以包括自焚基团,优选地是两个自焚基团。连接体可以包括O-取代的,例如,其中的氧原子被取代以与活性剂形成共价键连接;的碳原子被取代以与抗体形成共价键连接。
  • [EN] B-LYMPHOCYTE SPECIFIC AMATOXIN ANTIBODY CONJUGATES<br/>[FR] CONJUGUÉS D'ANTICORPS D'AMATOXINE SPÉCIFIQUES DE LYMPHOCYTES B
    申请人:HEIDELBERG PHARMA RES GMBH
    公开号:WO2021074261A1
    公开(公告)日:2021-04-22
    The present application relates to a conjugate comprising an amatoxin, a target-binding moiety wherein the target is CD20, i.e., a CD20-binding moiety, and optionally a linker linking said amatoxin and said CD20-binding moiety. The invention further relates to the synthesis of said conjugate. In addition, the invention relates to a pharmaceutical composition comprising such conjugate, particularly for use in the treatment of B-cell and/or lymphoma associated diseases and/or malignancies.
    本申请涉及一种共轭物,包括一种阿马氧甙、一种靶向结合基团,其中靶向是CD20,即CD20结合基团,以及可选的连接剂,连接所述阿马氧甙和所述CD20结合基团。本发明还涉及所述共轭物的合成。此外,本发明涉及一种药物组合物,包括这样的共轭物,特别是用于治疗B细胞和/或淋巴瘤相关疾病和/或恶性肿瘤。
  • SYNTHESIS OF ALPHA-AMANITIN AND ITS DERIVATIVES
    申请人:Pure Bioorganics SIA
    公开号:EP3792250A1
    公开(公告)日:2021-03-17
    The present invention relates to the chemical synthesis of α-amanitin and its derivatives. The present invention also relates to intermediate products of the α-amanitin synthesis.
    本发明涉及α-amanitin及其衍生物化学合成。本发明还涉及 α-amanitin 合成的中间产物。
  • Amatoxin derivatives and conjugates thereof as inhibitors of RNA polymerase
    申请人:NOVARTIS AG
    公开号:US10464969B2
    公开(公告)日:2019-11-05
    The invention disclosed herein relates to cytotoxic cyclic peptides of Formula (A), methods of inhibiting RNA polymerase with such cyclic peptides, immunoconjugates comprising such cyclic peptides (i.e Antibody Drug Conjugates), pharmaceutical compositions comprising such cyclic peptides immunoconjugates, compositions comprising such cyclic peptides immunoconjugates with a therapeutic co-agent and methods of treatment using such cyclic peptides immunoconjugates:
    本发明涉及式(A)的细胞毒性环肽、用这种环肽抑制 RNA 聚合酶的方法、包含这种环肽的免疫结合剂(即抗体药物结合剂)、包含这种环肽免疫结合剂的药物组合物、包含这种环肽免疫结合剂与治疗共用试剂的组合物以及使用这种环肽免疫结合剂的治疗方法:
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸